BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14586318)

  • 1. Toward a reduction of the global burden of cervical cancer.
    Rohan TE; Burk RD; Franco EL
    Am J Obstet Gynecol; 2003 Oct; 189(4 Suppl):S37-9. PubMed ID: 14586318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of human papillomavirus in carcinogenesis of cervical cancer and vaccination for HPV].
    Kariya M; Fujii S
    Uirusu; 2002 Dec; 52(2):287-93. PubMed ID: 12685321
    [No Abstract]   [Full Text] [Related]  

  • 3. Human papillomavirus, it's genes...and cancer vaccines.
    Steller MA
    Cancer Cell; 2003 Jan; 3(1):7-8. PubMed ID: 12559170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV vaccine trial may take place in India.
    Sharma DC
    Lancet Oncol; 2002 Nov; 3(11):649. PubMed ID: 12424057
    [No Abstract]   [Full Text] [Related]  

  • 5. [Can human papillomavirus testing and vaccination prevent cervical cancer?].
    Lie AK; Bjørge T; Helland A; Hagen B; Skjeldestad FE; Hagmar B; Thoresen S
    Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2947-51. PubMed ID: 11715778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus update with a particular focus on cervical disease.
    Garland SM
    Pathology; 2002 Jun; 34(3):213-24. PubMed ID: 12109780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer: screening and prevention.
    Behtash N; Mehrdad N
    Asian Pac J Cancer Prev; 2006; 7(4):683-6. PubMed ID: 17250453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Success of vaccine offers promise of cervical cancer prevention.
    Schultz J
    J Natl Cancer Inst; 2003 Jan; 95(2):102-4. PubMed ID: 12529341
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: a review.
    Tjiong MY; Out TA; Ter Schegget J; Burger MP; Van Der Vange N
    Int J Gynecol Cancer; 2001; 11(1):9-17. PubMed ID: 11285028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers.
    Ling M; Kanayama M; Roden R; Wu TC
    J Biomed Sci; 2000; 7(5):341-56. PubMed ID: 10971133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we really beat cervical cancer?
    Garland SM
    Med J Aust; 2003 Jun; 178(12):647-9. PubMed ID: 12797857
    [No Abstract]   [Full Text] [Related]  

  • 12. The molecular biology of cervical cancer.
    Münger K
    J Cell Biochem Suppl; 1995; 23():55-60. PubMed ID: 8747378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Viruses and cervical cancers].
    Mathevet P
    Rev Prat; 2001 Sep; 51(13):1413-6. PubMed ID: 11601069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 5: Viral and host factors in human papillomavirus persistence and progression.
    Wang SS; Hildesheim A
    J Natl Cancer Inst Monogr; 2003; (31):35-40. PubMed ID: 12807943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of carcinoma of cervix with human papillomavirus vaccine.
    Gavarasana S; Kalasapudi RS; Rao TD; Thirumala S
    Indian J Cancer; 2000; 37(2-3):57-66. PubMed ID: 11876611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of preventive human papillomavirus vaccination.
    Lehtinen M; Paavonen J
    Int J STD AIDS; 2003 Dec; 14(12):787-92. PubMed ID: 14678583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection.
    Franco EL; Duarte-Franco E; Ferenczy A
    CMAJ; 2001 Apr; 164(7):1017-25. PubMed ID: 11314432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of human papillomavirus vaccines in cervical neoplasia.
    Stern PL; Faulkner R; Veranes EC; Davidson EJ
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):783-99. PubMed ID: 11563873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
    Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
    Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.
    Goldie SJ; Kohli M; Grima D; Weinstein MC; Wright TC; Bosch FX; Franco E
    J Natl Cancer Inst; 2004 Apr; 96(8):604-15. PubMed ID: 15100338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.